Status:
COMPLETED
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Palo Alto Medical Foundation
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Prostate Cancer
Eligibility:
MALE
45+ years
Phase:
NA
Brief Summary
Researchers in this study will determine whether providing decision support interventions (DESIs) to men with low risk prostate cancer improves their decision-specific knowledge and alters their treat...
Detailed Description
Potentially eligible men (age 45 and older who have localized prostate cancer with a Gleason score of 6 or less) will be identified and recruited to participate in the study before their next office v...
Eligibility Criteria
Inclusion
- Age 45 or older Localized prostate cancer with a Gleason score of 6 or less
Exclusion
- Women
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT01244568
Start Date
December 1 2010
End Date
January 1 2013
Last Update
December 23 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States, 94301
2
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States, 27599